Trial · NCT01865084
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double Blind Period (DB) | STARTED | Placebo | 116 | |
| Double Blind Period (DB) | STARTED | 0.3 mg/kg Tadalafil | 102 | |
| Double Blind Period (DB) | STARTED | 0.6 mg/kg Tadalafil | 113 | |
| Double Blind Period (DB) | Received at Least One Dose of Study Drug | Placebo | 116 | |
| Double Blind Period (DB) | Received at Least One Dose of Study Drug | 0.3 mg/kg Tadalafil | 102 | |
| Double Blind Period (DB) | Received at Least One Dose of Study Drug | 0.6 mg/kg Tadalafil | 112 | |
| Double Blind Period (DB) | COMPLETED | Placebo | 111 | |
| Double Blind Period (DB) | COMPLETED | 0.3 mg/kg Tadalafil | 98 | |
| Double Blind Period (DB) | COMPLETED | 0.6 mg/kg Tadalafil | 107 | |
| Double Blind Period (DB) | NOT COMPLETED | Placebo | 5 | |
| Double Blind Period (DB) | NOT COMPLETED | 0.3 mg/kg Tadalafil | 4 | |
| Double Blind Period (DB) | NOT COMPLETED | 0.6 mg/kg Tadalafil | 6 | |
| Open Label Extension (OLE) Period | STARTED | Placebo | 0 | |
| Open Label Extension (OLE) Period | STARTED | 0.3 mg/kg Tadalafil | 150 | |
| Open Label Extension (OLE) Period | STARTED | 0.6 mg/kg Tadalafil | 165 | |
| Open Label Extension (OLE) Period | COMPLETED | Placebo | 0 | |
| Open Label Extension (OLE) Period | COMPLETED | 0.3 mg/kg Tadalafil | 139 | |
| Open Label Extension (OLE) Period | COMPLETED | 0.6 mg/kg Tadalafil | 158 | |
| Open Label Extension (OLE) Period | NOT COMPLETED | Placebo | 0 | |
| Open Label Extension (OLE) Period | NOT COMPLETED | 0.3 mg/kg Tadalafil | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01865084/flow